The purpose of this study is to identify the risk factors of bone metastasis in breast cancer patients so as to develop a dynamic prediction model using real world clinical data. The multicenter data will be retrospectively collected, and the clinical characteristics related to bone metastasis will be analyzed.
Patients diagnosed with breast cancer by histopathology;
Age between 20 and 70 years old;
The first diagnosis time is between 2010 and 2020;
Complete diagnosis and treatment information, including basic information, breast cancer diagnosis, surgery, recurrence diagnosis data (including the diagnosis of the metastasis sites), anti-tumor treatment data, bone health and bone metastasis-related diagnosis and treatment data, etc.;
Missing important basic information (including initial and recurrent pathology, stage, pathological grade and time, surgery time, and drug treatment);
With distant metastasis at the initial diagnosis;
Patients with autoimmune diseases or aggressive viral infections (such as HIV or hepatitis);
Other malignant tumors;
3500 breast cancer patients diagnosed between 2010 and 2020.
Cohort
Retrospective
Breast cancer patients with bone metastasis
Other interventionThis study is an observational study
Breast cancer patients without bone metastasis
Other interventionThis study is an observational study
To identify the risk factors and develop a prediction model for bone metastasis in breast cancer patients
The correlation between clinical characteristics and bone metastasis, and the accuracy of prediction model
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
